Skip Navigation Links
EDU360 Home
IGCS Website
IGCS Profile
IGCS Community
Membership
FAQ
International Journal of Gynecological Cancer
Menu
EDU360 Home
IGCS Website
IGCS Profile
IGCS Community
Membership
FAQ
International Journal of Gynecological Cancer
Hamburger Menu
Catalog
Calendar
Help
Catalog
Master Class: Managing Toxicities with TKIs in com ...
Master Class: Managing Toxicities with TKIs in combination with Checkpoint Inhibitors in Endometrial Cancer
Description
Recorded live: August 9, 2022
Click here to view supporting publication
Presenter:
Vicky Makker, MD
USA
Supported in part by
Summary
Availability:
On-Demand
Cost:
FREE
×
Master Class: Managing Toxicities with TKIs in combination with Checkpoint Inhibitors in Endometrial Cancer Course List
Create Account
Recommended
Learning Activity Title
Learning Activity Title
Learning Activity Title
Multidisciplinary Approach to Treating Advanced Endometrial Cancer
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Overall Survival Data with PARP Inhibitor: Myth vs. Reality - Webinar
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Multidisciplinary Approach to Treating Advanced Endometrial Cancer - Webinar
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Endometrial Cancer Tumor Board: Matching the right therapy to the right patient
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Tumor Board: How new data in cervical cancer effects second-line treatment options
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Radical Hysterectomy - Surgical Film Festival - Webinar
$0.00 - $50.00
Learning Activity Title
Learning Activity Title
Learning Activity Title
Treatment Options for Platinum Resistant Ovarian Cancer
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Overall Survival Data with PARP Inhibitor: Myth vs. Reality
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions - Webinar
FREE
Learning Activity Title
Learning Activity Title
Learning Activity Title
Study 309/Keynote-775: A Randomized, Phase 3 Study to Compare the Efficacy and Safety of Lenvatinib with Pembrolizumab vs Treatment of Physician’s Choice in Advanced Endometrial Cancer
FREE
Login
User Login
Continue with Google
OR
Login Name
Password
Logging In…
Create Account
Forgot Password
Contact
education@igcs.org
for assistance.
×
Please select your language
1
English